Merck's plant gets European nod to make JnJ Covid-19 vaccine
New Delhi: The European Medicines Agency (EMA) said on Thursday it had approved U.S. drugmaker Merck & Co Inc's manufacturing site in West Point, Pennsylvania to make Johnson & Johnson's COVID-19 vaccine.Earlier this year, Merck agreed to make its rival's shot, after scrapping two of its own experimental COVID-19 vaccines.Also Read:JnJ plans to seek USFDA authorization for booster shot...
New Delhi: The European Medicines Agency (EMA) said on Thursday it had approved U.S. drugmaker Merck & Co Inc's manufacturing site in West Point, Pennsylvania to make Johnson & Johnson's COVID-19 vaccine.
Earlier this year, Merck agreed to make its rival's shot, after scrapping two of its own experimental COVID-19 vaccines.
Also Read:JnJ plans to seek USFDA authorization for booster shot of Covid-19 vaccine
The U.S. government at that time invoked the Defense Production Act to help equip two Merck plants to make the J&J vaccine.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd